Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency

Developmental Medicine and Child Neurology

Volumn 51, Issue 7, 2009, Pages 563-567

  Akman, Cigdem I ^a,d   Patterson, Marc C ^a   Rubinstein, Arye ^b   Herzog, Ronit ^c  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; ETIRACETAM; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; LAMOTRIGINE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ACADEMIC FAILURE; ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CONFUSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; HIP PAIN; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; OSTEOMYELITIS; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; REPEAT PROCEDURE; SCLEROSIS; SEIZURE; TREATMENT DURATION; TREATMENT RESPONSE;

ACUTE DISEASE; ADOLESCENT; AGAMMAGLOBULINEMIA; ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; LIMBIC ENCEPHALITIS; METHYLPREDNISOLONE; TREATMENT OUTCOME;

EID: 67049095534     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2008.03217.x     Document Type: Article

References (16)

1. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966; 2: 512-14.
2. Vincent A, Lang B, Kleopa KA. Autoimmune channelopathies and related neurological disorders. Neuron 2006; 52: 123-38.
3. Tuzun E, Dalmau J. Limbic encephalitis and variants: Classification, diagnosis and treatment. Neurologist 2007; 13: 261-71.
4. Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 2001; 1: 421-29.
5. Lyon G, Griscelli C, Fernandez-Alvarez E, et al. Chronic progressive encephalitis in children with x-linked hypogammaglobulinemia. Neuropadiatrie 1980; 11: 57-71.
6. Rudge P, Webster AD, Revesz T, et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain 1996; 119: 1-15.
7. Smith J, Fernando T, McGrath N, et al. Lamotrigine-induced common variable immune deficiency. Neurology 2004; 62: 833-34.
8. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005; 128: 1764-77.
9. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
10. Mata S, Muscas GC, Naldi I, et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 2008; 199: 155-59.
11. Darnell RB, Victor J, Rubin M, et al. A novel antineuronal antibody in stiff-man syndrome. Neurology 1993; 43: 114-20.
12. Peltola J, Kulmala P, Isojarvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000; 55: 46-50.
13. Vulliemoz S, Vanini G, Truffert A, et al. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry 2007; 78: 187-89.
14. Bjork E, Velloso LA, Kampe O, et al. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43: 161-65.
15. Rekand T, Vedeler C, Gramstad A, et al. Hashimoto's encephalopathy: A treatable cause of mental impairment, stroke and seizures. Eur J Neurol 2003; 10: 746-47.
16. Novillo-Lopez ME, Rossi JE, Dalmau J, et al. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology 2008; 70: 728-29.